Chester County News and Community Website
The Centers for Disease Control and Prevention (CDC) has recently announced the release of more than 77,000 additional doses of Beyfortus™ (nirsevimab-alip (100 mg)), a long-acting monoclonal antibody designed to …
CDC Announces Release of Over 77,000 Additional Doses of Beyfortus™ for RSV Protection in Infants Read More
The US adalimumab biosimilars market has recently seen a significant increase in competition with the introduction of several new products, according to Spherix Global Insights.s. This shift has had a …
The Surge of Adalimumab Biosimilars in the US Market and Its Impact on Chester County’s Life Sciences Industry Read More
With psoriasis impacting over 8 million Americans, the continual search for improved treatments is essential. Fortunately, a recent study from Spherix Global Insights, the Chester County-based market research company for …
The Future of Plaque Psoriasis Treatment: A Shift Towards Oral Medication Read More
CDC is recommending a new immunization starting this fall to help protect all infants under 8 months and some older babies at increased risk of severe illness caused by respiratory …
New CDC Immunization: Protecting Infants & Babies from Severe Illness caused by RSV Read More